Biocept awarded broad japanese patent for the use of binding entities in combination with any solid surface to capture and detect any target of interest, including ctcs, from any sample type

San diego, nov. 5, 2020 /prnewswire/ -- biocept, inc. (nasdaq: bioc), a leading commercial provider of molecular diagnostic tests, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, announces that it has been awarded...
BIOC Ratings Summary
BIOC Quant Ranking